Format

Send to

Choose Destination
Cardiol Rev. 2017 Mar/Apr;25(2):77-83. doi: 10.1097/CRD.0000000000000105.

On-X Valve: The Next Generation Aortic Valve.

Author information

1
From the *Department of Medicine, Sinai Hospital of Baltimore, Johns Hopkins University, Baltimore, MD; †Division of Cardiology, Lehigh Valley Health Network, Allentown, PA; and ‡Department of Medicine, Einstein Healthcare Network, Philadelphia, PA.

Abstract

The On-X valve is a newer generation mechanical bileaflet valve. Its key features include the use of pure pyrolytic carbon (devoid of silicon), a length-to-diameter ratio similar to a native valve, an inlet flared orifice, a leaflet opening up to 90 degrees, a shorter leaflet closing angle, a 2-point leaflet contact, and an actuated pivot. These features have translated into increased strength, improved valve hemodynamics, reduced hemolysis, and thrombogenicity. The 2014 American Heart Association/American College of Cardiology guidelines for the management of patients with valvular heart disease recommend an international normalized ratio (INR) of 2.5 (range, 2-3) in patients with a mechanical valve at the aortic position. However, based on the results of the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT), the Food and Drug Administration approved this valve in April 2015 in the aortic position with a lower INR goal of 1.5-2.0. This reduction in INR goals led to a statistically significant reduction in the combined endpoint of clots, bleeding events, and stroke rates with 9/patient-years for the lower INR group compared with 12/patient-years in the standard INR group. This review compares the currently available literature on the On-X valve with that of other contemporary valves.

PMID:
28170357
DOI:
10.1097/CRD.0000000000000105
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center